LUPIN LIMITED Financial Ratios
LUPIN · Healthcare · Current price ₹2,443.2
P/E ratio
20.9x
P/B ratio
4.9x
ROE
29.1%
ROCE
30.0%
Debt / Equity
0.29
Dividend yield
0.7%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 20.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 4.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 29.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 30.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.29 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with LUPIN LIMITED's latest numbers.
LUPIN LIMITED profitability
LUPIN LIMITED generates a return on equity of 29.1% and a return on capital employed of 30.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.29 and a P/E of 20.9x, LUPIN LIMITED is conservatively financed. Our overall business-quality score for the company is 7.0 / 10.
Understand the ratios
More on LUPIN LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.